Cargando…
Inhibition of IGF-1 Signalling Enhances the Apoptotic Effect of AS602868, an IKK2 Inhibitor, in Multiple Myeloma Cell Lines
Multiple myeloma (MM) is a B cell neoplasm characterized by bone marrow infiltration with malignant plasma cells. IGF-1 signalling has been explored as a therapeutic target in this disease. We analyzed the effect of the IKK2 inhibitor AS602868, in combination with a monoclonal antibody targeting IGF...
Autores principales: | Tagoug, Ines, Sauty De Chalon, Amélie, Dumontet, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143180/ https://www.ncbi.nlm.nih.gov/pubmed/21799925 http://dx.doi.org/10.1371/journal.pone.0022641 |
Ejemplares similares
-
Analysis of the anti-proliferative and the pro-apoptotic efficacy of Syk inhibition in multiple myeloma
por: Koerber, Ruth-Miriam, et al.
Publicado: (2015) -
Real life management of patients hospitalized with multiple myeloma in France
por: Dumontet, Charles, et al.
Publicado: (2018) -
Apoptotic Machinery Diversity in Multiple Myeloma Molecular Subtypes
por: Gomez-Bougie, Patricia, et al.
Publicado: (2013) -
Targeting IKKβ in Cancer: Challenges and Opportunities for the Therapeutic Utilisation of IKKβ Inhibitors
por: Prescott, Jack A., et al.
Publicado: (2018) -
Abnormal IGF-Binding Protein Profile in the Bone Marrow of Multiple Myeloma Patients
por: Bieghs, Liesbeth, et al.
Publicado: (2016)